ADD ANI AS A TRUSTED SOURCE
googleads
ANI Logo
Menu
Health

Visible light activates molecular machineries to treat infections: Study

Houston (Texas) [US] June 5 (ANI): Scientists have demonstrated that light-activated molecular machines can drill holes through gram-negative and gram-positive bacteria membranes, killing them in as little as two minutes. Their study suggests a new way to combat antibiotic-resistant bacteria, which lack natural defences against mechanical intruders.

ANI Jun 05, 2022 15:39 IST googleads

Representative image

Houston (Texas) [US] June 5 (ANI): Scientists have demonstrated that light-activated molecular machines can drill holes through gram-negative and gram-positive bacteria membranes, killing them in as little as two minutes. Their study suggests a new way to combat antibiotic-resistant bacteria, which lack natural defences against mechanical intruders.
The study has been published in the journal, "Science Advances, 2022"
The latest iteration of nanoscale drills developed at Rice University is activated by visible light rather than ultraviolet (UV), as in earlier versions. These have also proven effective at killing bacteria through tests on real infections.
Six variants of molecular machines were successfully tested by Rice chemist James Tour and his team. All of them punched holes in the membranes of gram-negative and gram-positive bacteria in as little as two minutes. Resistance was futile for bacteria that have no natural defences against mechanical invaders. That means they are unlikely to develop resistance, potentially offering a strategy to defeat bacteria that have become immune to standard antibacterial treatments over time.
"I tell students that when they are my age, antibiotic-resistant bacteria are going to make COVID look like a walk in the park," Tour said. "Antibiotics won't be able to keep 10 million people a year from dying of bacterial infections. But this really stops them."
Because extended exposure to UV can be damaging to humans, the Rice lab has been refining its molecules for years. The new version gets its energy from still-blueish light at 405 nanometers, spinning the molecules' rotors at 2 to 3 million times per second.
It's been suggested by other researchers that light at that wavelength has mild antibacterial properties of its own, but the addition of molecular machines supercharges it, said Tour, who suggested bacterial infections like those suffered by burn victims and people with gangrene will be early targets.
The machines are based on Nobel Prize-winning work by Bernard Feringa, who developed the first molecule with a rotor in 1999 and got the rotor to spin reliably in one direction. Tour and his team introduced their advanced drills in a 2017 Nature paper.
The Rice lab's first tests of the new molecules on burn wound infection models confirmed their ability to quickly kill bacteria, including methicillin-resistant Staphylococcus aureus, a common cause of skin and soft tissue infections that was responsible for more than 100,000 deaths in 2019.
The team achieved visible light activation by adding a nitrogen group. "The molecules were further modified with different amines in either the stator (stationary) or the rotor portion of the molecule to promote the association between the protonated amines of the machines and the negatively charged bacterial membrane," said Liu, now a scientist at Arcus Biosciences in California.
The researchers also found the machines effectively break up biofilms and persister cells, which become dormant to avoid antibacterial drugs.
"Even if an antibiotic kills most of a colony, there are often a few persister cells that for some reason don't die," Tour said. "But that doesn't matter to the drills."
As with earlier versions, the new machines also promise to revive antibacterial drugs considered ineffective. "Drilling through the microorganisms' membranes allows otherwise ineffective drugs to enter cells and overcome the bug's intrinsic or acquired resistance to antibiotics," said Santos, who's on the third year of the postdoctoral global fellowship that brought her to Rice for two years and is continuing at the Health Research Institute of the Balearic Islands in Palma, Spain.
The lab is working toward better targeting bacteria to minimize damage to mammalian cells by linking bacteria-specific peptide tags to the drills to direct them toward pathogens of interest. "But even without that, the peptide can be applied to a site of bacterial concentration, like in a burn wound area," Santos said. (ANI)

Get the App

What to Read Next

Health

This new drug could be first to stop deadly fatty liver disease

This new drug could be first to stop deadly fatty liver disease

The Researchers at the University of California San Diego School of Medicine have identified a new investigational drug that shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease linked to obesity and type 2 diabetes that can lead to cirrhosis, liver failure, and even liver cancer.

Read More
Health

Scientists uncover key protein in cellular fat storage: Study

Scientists uncover key protein in cellular fat storage: Study

Research conducted at the University of New South Wales (UNSW) has shed light on how cells in the body manage and store fat, potentially offering new insights into human health.

Read More
Health

Surgery to treat chronic sinus disease more effective

Surgery to treat chronic sinus disease more effective

A comprehensive clinical trial sponsored by University College London (UCL), the University of East Anglia, and Guy's and St Thomas' NHS Foundation Trust found that sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis.

Read More
Health

Mosquito killing pill, Ivermectin drops malaria by 26%: Study 

Mosquito killing pill, Ivermectin drops malaria by 26%: Study 

A groundbreaking study has revealed that the mass administration of ivermectin--a drug once known for treating river blindness and scabies--can significantly reduce malaria transmission when used in conjunction with bed nets.

Read More
Health

Researchers new AI implant promises drug-free pain relief

Researchers new AI implant promises drug-free pain relief

A groundbreaking wireless implant promises real-time, personalised pain relief using AI and ultrasound power, no batteries, no wires, and no opioids. Designed by University of Southern California (USC) and University of California, Los Angeles (UCLA) engineers, it reads brain signals, adapts on the fly, and bends naturally with your spine.

Read More
Health

Millions of new solar system objects to be found: Study

Millions of new solar system objects to be found: Study

A group of astronomers from across the globe, including a team from the University of Washington and led by Queen's University Belfast, have revealed new research showing that millions of new solar system objects will be detected by a brand-new facility, which is expected to come online later this year.

Read More
Health

Light exercise can help slow cognitive decline in Alzheimer's

Light exercise can help slow cognitive decline in Alzheimer's

Researchers at University of California San Diego and Wake Forest University have found that both low and moderate-high intensity exercise could be valuable tools in the fight against Alzheimer's.

Read More
Health

Study finds a unique sound which alleviates motion sickness

Study finds a unique sound which alleviates motion sickness

A research group has discovered that using a device that stimulates the inner ear with a specific wavelength of sound reduces motion sickness.

Read More
Health

Biomedical engineers build world's smallest pacemaker 

Biomedical engineers build world's smallest pacemaker 

A tiny pacemaker is paired with a small, soft, flexible wearable patch that sits on the patient's chest. The wearable patch detects irregular heartbeats and automatically emits pulses of light.

Read More
Health

New eye drops slow vision loss in animals: Study

New eye drops slow vision loss in animals: Study

Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.